ストックスクリーナーアプリを入手
13.10
0.08%
0.010
プレマーケット:
13.19
0.09
+0.69%
前日終値:
$13.09
開ける：
$13.09
24時間の取引高:
2.65M
Relative Volume:
1.42
時価総額：
$747.81M
収益：
-
当期純損益:
$-72.89M
株価収益率:
-5.4132
EPS:
-2.42
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
+3.97%
1か月 パフォーマンス:
+6.94%
6か月 パフォーマンス:
+148.11%
1年 パフォーマンス:
+29.19%
1日の値動き範囲:
$13.06
$13.29
1週間の範囲:
$12.55
$13.29
52週間の値動き範囲:
$3.555
$13.29
Astria Therapeutics Inc Stock (ATXS) Company Profile
ATXS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
13.10 | 747.24M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-09-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-01-31 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-29 | 開始されました | TD Cowen | Buy |
| 2023-03-28 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Astria Therapeutics Inc (ATXS) 最新ニュース
Will Astria Therapeutics Inc. stock gain from government policies2025 Market Overview & Verified Swing Trading Watchlists - Newser
Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume IncreaseWhat's Next? - MarketBeat
BioCryst’s Ongoing Boost: Buy or Watch? - StocksToTrade
Astria Therapeutics (NASDAQ:ATXS) Sets New 1-Year HighWhat's Next? - MarketBeat
Astria Therapeutics (ATXS) Acquisition Moves Forward with Antitr - GuruFocus
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition - The Manila Times
BioCryst Pharmaceuticals Announces Early Termination of HSR Waiting Period for Astria Therapeutics Acquisition - Quiver Quantitative
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-TCBX, RNA, ATXS, and FSUN - The Malaysian Reserve
Trading the Move, Not the Narrative: (ATXS) Edition - news.stocktradersdaily.com
Astria Therapeutics: Updating Target Price, BioCryst Deal Expected To Go Through, Hold - Seeking Alpha
Why Astria Therapeutics Inc. stock could outperform in 2025Weekly Trade Summary & High Accuracy Buy Signal Tips - moha.gov.vn
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN - The Malaysian Reserve
Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
(ATXS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Will Astria Therapeutics Inc. stock split again soonJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
How Astria Therapeutics Inc. stock performs in interest rate cycles2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Will Astria Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Review & Weekly High Potential Alerts - newser.com
Can Astria Therapeutics Inc. stock deliver surprise earnings beatWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
Can Astria Therapeutics Inc. stock outperform in 2025 bull marketPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Combining price and volume data for Astria Therapeutics Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Why Astria Therapeutics Inc. is moving todayJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is this a good reentry point in Astria Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will Astria Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & AI Driven Stock Reports - newser.com
Is Astria Therapeutics Inc. stock a contrarian buyJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Is Astria Therapeutics Inc. stock overvalued by current metrics2025 Price Action Summary & High Return Trade Guides - newser.com
Astria Therapeutics Inc. (ATXS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Astria Therapeutics Inc. stock is in analyst buy zoneQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
Multi factor analysis applied to Astria Therapeutics Inc.Quarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Is Astria Therapeutics Inc. trending in predictive chart modelsGDP Growth & Community Verified Trade Signals - newser.com
Will Astria Therapeutics Inc. stock maintain dividend yield2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Astria Therapeutics Inc (ATXS) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):